<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Predictive Power and Implication of EuroSCORE, EuroSCORE II and STS Score for Isolated Repeated Aortic Valve Replacement</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Sebastian</forename><surname>Holinski</surname></persName>
							<email>sebastian.holinski@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">Charité Hospital</orgName>
								<orgName type="institution" key="instit2">Medi-cal University</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sören</forename><surname>Jessen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">Charité Hospital</orgName>
								<orgName type="institution" key="instit2">Medi-cal University</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Konrad</forename><surname>Neumann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Biometry</orgName>
								<orgName type="institution" key="instit1">Charité Hospital</orgName>
								<orgName type="institution" key="instit2">Medical University</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Wolfgang</forename><surname>Konertz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">Charité Hospital</orgName>
								<orgName type="institution" key="instit2">Medi-cal University</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">Charité Hospital</orgName>
								<orgName type="institution" key="instit2">Medical University</orgName>
								<address>
									<addrLine>Schumannstr. 20/21</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin, Berlin</settlement>
									<country>Germany, Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Predictive Power and Implication of EuroSCORE, EuroSCORE II and STS Score for Isolated Repeated Aortic Valve Replacement</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">6565CCB7227D7DA00F96F482D24CD075</idno>
					<idno type="DOI">10.5761/atcs.oa.14-00100</idno>
					<note type="submission">Received: March 25, 2014; Accepted: September 17, 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Euroscore</term>
					<term>STS score</term>
					<term>operative risk models</term>
					<term>aortic valve reoperation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objective: We evaluated the predictive power of the EuroSCORE, EuroSCORE II and Society of Thoracic Surgeons (STS) score for isolated redo aortic valve replacement.</s><s>Materials and Methods: 78 consecutive patients underwent the aforementioned procedure mainly with a stentless valve prosthesis at our institution.</s><s>Observed mortality was compared to the predicted mortality, Receiver Operating Characteristics (ROC) curves were calculated and the area under the curve (AUC) analyzed.</s><s>Result: Observed mortality was 11.5%.</s><s>EuroSCORE and EuroScore II predicted a mortality of 28.2 ± 21.6% (p &lt;0.001) and 10.2 ± 11.8% (p = 0.75), respectively.</s><s>AUC of the EuroSCORE was 0.74 (95% CI: 0.62-0.83),</s><s>p = 0.009 and of the EuroSCORE II 0.86 (95% CI: 0.76-0.93),</s><s>p &lt;0.0001.</s><s>Optimal Youden index of the EuroSCORE II was 0.59 refering to a predicted mortality of 9.9% (sensitivity: 77.8% and specificity: 81.2%).</s><s>Predicted mortality of STS score was 17.8 ± 10.6% (p = 0.08) and AUC was 0.64 (95% CI: 0.53-0.75),</s><s>p = 0.06.</s><s>Conclusion: EuroSCORE II calculation was not only superior to EuroSCORE and STS score but led to a very realistic mortality prediction for this special procedure at our institution.</s><s>A EuroSCORE II greater 10 should encourage to consider an alternative treatment.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Repeated aortic valve replacement has a considerably higher morbidity and mortality than the initial procedure particularly in patients undergoing emergency reoperation. <ref type="bibr" target="#b0">1)</ref></s><s>]<ref type="bibr" target="#b3">[4]</ref> Their predictive value for this special procedure needs to be evaluated since they based mainly on coronary patients and primary procedures.</s><s>However, a precise risk algorithm is required to decide when to perform standard redo-operation or an alternative treatment like valve-in-valve TAVI which is an option at least in patients without active endocarditis. <ref type="bibr" target="#b4">5)</ref></s><s>Therefore we compared our institutional results with the predictions of the EuroSCORE, EuroSCORE II and Society of Thoracic Surgeons (STS) score.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and Operation</head><p><s>Between January 2004 and September 2011, 78 Patients with a mean age of 66 ± 11 years underwent isolated repeated aortic valve replacement at the Charité University Hospital Berlin.</s><s>Main indication was severe regurgitation with or without stenosis.</s><s>Active prosthetic valve endocarditis was present in 49% of the patients.</s><s>Further characterization of this cohort is provided in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Operation was performed with median resternotomy, ascending aortic and right atrial cannulation, normothermic cardiopulmonary bypass, direct aortic clamping as well as intermittent, antegrade warm blood cardioplegia.</s><s>A biological prosthesis was implanted in 92% of the patients.</s><s>97% of the biological prostheses were stentless.</s><s>An overview of implanted prostheses provides Table <ref type="table" target="#tab_1">2</ref>. Standard transthoracic echocardiography was performed at discharge with a HP Sonos 5500 (Hewlett-Packard, Palo Alto, California, USA) or a GE Vivid 7 Dimension (General Electric, Fairfield, Connecticut, USA) to check function of implanted prostheses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>EuroSCORE, EuroSCORE II and STS score were calculated according to their definition.</s><s>Observed mortality was compared to the predicted mortality using a version of the binomial-test based on the parametric bootstrap method.</s><s>Receiver Operating Characteristics (ROC) curves were calculated and the area under the curve (AUC) analyzed.</s><s>Moreover, Youden's index (= Sensitivity + Specificity -1) was calculated which captures the performance of a diagnostic test.</s><s>Statistical calculations were performed using MedCalc version 12.4.06</s><s>(Med-Calc Software, Ostend Belgium) and SPSS 19 (IBM, Armonk, New York, USA).</s><s>Level of significance was 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Mean Aortic Cross Clamp time and duration of cardiopulmonary bypass was 95 and 125 minutes respectively.</s><s>There was a median blood loss including serous drainage of 830 ml.</s><s>65% of the patients were extubated within 24 h.</s><s>Median of ICU and hospital stay were 3 and 13 days.</s><s>Maximum and mean pressure gradients of the aortic valve prostheses at discharge were 24/14 mmHg.</s><s>No patient died during the operation.</s><s>30-day mortality was 6.5%.</s><s>Another 5% died after the 30th postoperative day but within the same hospital admission.</s><s>Thus, the actual combined mortality due to the EuroSCORE mortality definition was 11.5%.</s><s>Causes of death were septic, therapy-resistant prosthetic valve endocarditis in six patients, pneumonia in two patients and intractable hemorrhagic shock in one patient.</s><s>The predicted combined mortality according to the mean logistic EuroSCORE of CVA occurred in one patient (1.3%) and a permanent pace maker was required in 11 patients (14.1%).</s><s>No patient suffered from myocardial infarction.</s><s>Three patients had to be reoperated during the same hospital stay.</s><s>Recurrent rapid prosthetic endocarditis was the indication for reoperation in two cases.</s><s>Another stentless bioprosthesis (Sorin Solo) had to be replaced because of symptomatic valvular stenosis due to oversizing.</s><s>All complications are listed in Table <ref type="table" target="#tab_2">3</ref>. the cohort was 28.2 ± 21.6% which was significantly different from the observed mortality (p &lt;0.001).</s><s>AUC of the EuroSCORE was 0.74 (95% CI: 0.62-0.83),</s><s>which was significantly different from the random resembling diagonal line (p = 0.009).</s><s>Youden index is 0.42 for a mortality of 63.5% with a sensitivity of 44.4% and a specifity of 97.1%.</s><s>The logistic EuroSCORE II predicted a mortality of 10.2 ± 11.8% which was not significantly different from the observed mortality (p = 0.75).</s><s>AUC (Fig. <ref type="figure">1</ref>) of the EuroSCORE II was 0.86 (95% CI: 0.76-0.93),</s><s>p &lt;0.0001.</s><s>Youden index is 0.59 for a mortality of 9.9% with a sensitivity of 77.8% and a specifity of 81.2 %.</s></p><p><s>Predicted mortality of STS score was 17.8 ± 10.6% (p = 0.08) and AUC was 0.64 (95% CI: 0.53-0.75),</s><s>p = 0.06.</s><s>Youden index is 0.37 for a mortality of 16.8% with a sensitivity of 77.8% and a specifity of 59.4%.</s><s>Comparison of observed and predicted morbidities according to the STS score criteria are provided in Table <ref type="table" target="#tab_3">4</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Statistical models to estimate the operative risk for a specific procedure and patient can be very helpful to decide if to operate and which procedure should be performed.</s><s>This study investigated the risks of patients undergoing standard isolated repeated aortic valve replacement.</s><s>Several risk models exist to predict operative mortality for cardiac surgical patients.</s><s>The most commonly used Euro-SCORE, 2) EuroSCORE II <ref type="bibr" target="#b2">3)</ref> and STS score <ref type="bibr" target="#b3">4)</ref> were chosen and their predictive power evaluated for our redo AVR patients.</s><s>As previously described the EuroSCORE significantly overestimated the risk of patients undergoing aortic valve surgery. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7)</ref></s><s>These rough predictions especially for valve procedures <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9)</ref> can be explained by the fact that the data base of the EuroSCORE consists mainly of coronary patients.</s><s>Only 17% were aortic valve procedures with probably a much smaller but not reported percentage of patients undergoing redo AVR operation. <ref type="bibr" target="#b9">10)</ref></s><s>nother reason is that the data base was completed almost two decades ago with improvements of surgical techniques and intensive care in between.</s><s>In order to overcome these problems the EuroSCORE II was developed based on data of more than 22.000 patients operated in 43 countries all over the world in 2010. <ref type="bibr" target="#b2">3)</ref></s><s>Moreover, the rate of aortic valve patients in the EuroSCORE II database was twice as high compared to the predecessor.</s><s>In fact, the EuroSCORE II predicted the mortality of our patients quite precise and much better than the EuroSCORE.</s><s>Moreover it was also superior over the STS Score although the STS score is based on much more patients (67.000) and parameters. 4)</s><s>However, only centers in the USA provided data and patients were operated before 2007.</s><s>Predicted non-pure mortality endpoints of the STS score apart from deep sternal wound infections and length of stay did also not match well with our results.</s><s>Either this special patient subgroup is not well represented in the STS database or our results are not representative.</s><s>This leads to one limitation of our study which is the relative small number of patients included in the study referring to a rather infrequent complication like mortality.</s><s>Since there were only nine deaths a larger study population would be desirable.</s><s>Nevertheless, we conclude that EuroSCORE II calculation was not only superior to EuroSCORE and STS score but led to a very realistic mortality prediction for our patients undergoing isolated, repeated aortic valve replacement.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 Patient characteristics</head><label>1</label><figDesc></figDesc><table><row><cell>Characteristics</cell><cell>number</cell><cell>mean ± SD (%)</cell></row><row><cell>Patients</cell><cell>78</cell><cell>100%</cell></row><row><cell>Age, yrs</cell><cell>66 ± 11</cell><cell></cell></row><row><cell>Female gender</cell><cell>17</cell><cell>22%</cell></row><row><cell>Height, cm</cell><cell>174 ± 9</cell><cell></cell></row><row><cell>Weight, kg</cell><cell>77 ± 14</cell><cell></cell></row><row><cell>Extracardiac arteriopathy</cell><cell>9</cell><cell>12%</cell></row><row><cell>Chronic obstructive pulmonary disease</cell><cell>8</cell><cell>10%</cell></row><row><cell>Neurologic dysfunction</cell><cell>13</cell><cell>17%</cell></row><row><cell>Critical preoperative state</cell><cell>8</cell><cell>10%</cell></row><row><cell>Renal dysfunction</cell><cell></cell><cell></cell></row><row><cell>Dialysis</cell><cell>6</cell><cell>8%</cell></row><row><cell>Creatinin clearance &lt;50 ml/min</cell><cell>24</cell><cell>31%</cell></row><row><cell>Creatinin clearance 50 ml-85 ml</cell><cell>27</cell><cell>35%</cell></row><row><cell>Insulin dependent diabetes mellitus</cell><cell>8</cell><cell>10%</cell></row><row><cell>Arterial hypertension</cell><cell>72</cell><cell>92%</cell></row><row><cell>Immunosupression</cell><cell>5</cell><cell>6%</cell></row><row><cell>Impaired mobility</cell><cell>13</cell><cell>17%</cell></row><row><cell>Left ventricular ejection fraction</cell><cell></cell><cell></cell></row><row><cell>&gt;50%</cell><cell>45</cell><cell>58%</cell></row><row><cell>31%-50%</cell><cell>29</cell><cell>37%</cell></row><row><cell>21%-30%</cell><cell>2</cell><cell>3%</cell></row><row><cell>≤20%</cell><cell>1</cell><cell>1%</cell></row><row><cell>Systolic pulmonary artery pressure</cell><cell></cell><cell></cell></row><row><cell>31 mmHg-55 mmHg</cell><cell>2</cell><cell>3%</cell></row><row><cell>≥55 mmHg</cell><cell>8</cell><cell>10%</cell></row><row><cell>CCS class 4 angina</cell><cell>0</cell><cell>0%</cell></row><row><cell>Recent myocardial infarction</cell><cell>2</cell><cell>3%</cell></row><row><cell>Arrhytmia</cell><cell>14</cell><cell>18%</cell></row><row><cell>Active prosthetic valve endocarditis</cell><cell>38</cell><cell>49%</cell></row><row><cell>Emergency</cell><cell>2</cell><cell>3%</cell></row><row><cell cols="3">SD: standard deviation; CCS: Canadian Cardiovascular Society</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 Implanted valve prostheses</head><label>2</label><figDesc></figDesc><table><row><cell>Type</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 Frequency of postoperative complications</head><label>3</label><figDesc></figDesc><table><row><cell>Complications</cell><cell>Patients</cell><cell>No (%)</cell></row><row><cell>Renal Failure (STS definition)</cell><cell>15</cell><cell>19%</cell></row><row><cell>Pneumonia</cell><cell>15</cell><cell>19%</cell></row><row><cell>Sepsis</cell><cell>13</cell><cell>17%</cell></row><row><cell>Re-exploration for Bleeding/tamponade</cell><cell>8</cell><cell>10%</cell></row><row><cell>Low Cardiac Output</cell><cell></cell><cell></cell></row><row><cell>IABP</cell><cell>5</cell><cell>6%</cell></row><row><cell>VAD</cell><cell>1</cell><cell>1%</cell></row><row><cell>Stroke</cell><cell>1</cell><cell>1%</cell></row><row><cell>Mediastinitis (STS definition)</cell><cell>1</cell><cell>1%</cell></row><row><cell>AV-block III requiring PM implant</cell><cell>11</cell><cell>14%</cell></row><row><cell>Myocardial infarction</cell><cell>0</cell><cell>0%</cell></row><row><cell>Gastrointestinal complication</cell><cell>1</cell><cell>1%</cell></row><row><cell>Reoperation for valve dysfunction</cell><cell>3</cell><cell>4%</cell></row><row><cell>STS: Society of Thoracic Surgeons</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 Observed and predicted non-pure mortality endpoints of the STS score</head><label>4</label><figDesc></figDesc><table><row><cell>Criteria</cell><cell>Observed (%)</cell><cell>Predicted (%)</cell><cell>p</cell></row><row><cell>Morbidity and mortality</cell><cell>39.7</cell><cell>66.8</cell><cell>0.000</cell></row><row><cell>Long length of stay</cell><cell>44.9</cell><cell>41.8</cell><cell>0.64</cell></row><row><cell>Short length of stay</cell><cell>7.7</cell><cell>7.6</cell><cell>1.00</cell></row><row><cell>Permanent stroke</cell><cell>1.3</cell><cell>7.6</cell><cell>0.03</cell></row><row><cell>Prolonged ventilation</cell><cell>32.8</cell><cell>52.1</cell><cell>0.001</cell></row><row><cell>Deep sternal wound infection</cell><cell>1.3</cell><cell>0.3</cell><cell>0.19</cell></row><row><cell>Renal failure</cell><cell>15.3</cell><cell>47.3</cell><cell>0.000</cell></row><row><cell>Reoperation</cell><cell>19.2</cell><cell>23.5</cell><cell>0.000</cell></row></table><note><p><s>STS: Society of Thoracic SurgeonsFig.1 ROC curve of EuroSCORE II.</s><s>ROC: Receiver Operating Characteristics.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Ann Thorac Cardiovasc Surg Vol. 21, No.3 (2015)   </note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>The authors have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Perioperative risk of redo aortic valve replacement</title>
		<author>
			<persName><forename type="first">S</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Autschbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="105" to="110" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The logistic EuroSCORE</title>
		<author>
			<persName><forename type="first">F</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Goldstone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="881" to="882" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Nashef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Sharples</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="734" to="744" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>discussion 744-5</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Shahian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filardo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="S23" to="42" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Valvein-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves</title>
		<author>
			<persName><forename type="first">H</forename><surname>Eggebrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schäfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Treede</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1218" to="1227" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Performance of the original EuroSCORE</title>
		<author>
			<persName><forename type="first">S</forename><surname>Siregar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Groenwold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Heer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="746" to="754" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">EuroSCORE: a systematic review of international performance</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gogbashian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sedrakyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Treasure</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="695" to="700" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A question of clinical reliability: observed versus EuroSCORE-predicted mortality after aortic valve replacement</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ghazy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kappert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ouda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Heart Valve Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="16" to="20" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Overestimation of the operative risk by the EuroSCORE also in high-risk patients undergoing aortic valve replacement with a stentless biological prosthesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Holinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claus</forename><forename type="middle">B</forename><surname>Christ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Surg Forum</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="E13" to="16" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Nashef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Michel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="816" to="822" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
